Article | October 21, 2024 What the DOJ Looks For: Key Insights into Evaluating Your Compliance Program Read More
Article | October 10, 2024 Gardner Law Launches Litigation Practice with Renowned Attorney David Graham Read More
Article | October 01, 2024 Latest Untitled Letter from FDA’s OPDP Underscores Need for Careful Approach to Advertising Read More
Article | September 05, 2024 Navigating the Biosecure Act: Implications for Biotechnology and Pharmaceutical Companies Read More
Article | August 27, 2024 Kickbacks and Consequences: Lessons from the Innovasis Settlement Read More
Article | August 14, 2024 FDA Faces Pressure to Enhance Oversight of Online Prescription Drug Promotions Read More
Article | August 01, 2024 FDA Unveils Criteria for Reporting Real-World Evidence (RWE) Submissions Read More
Article | July 10, 2024 Privacy Summer School: 10 Things You Should Know About Privacy, Consent, and HIPAA Read More
Article | June 27, 2024 Expert Insights from In-House Lawyers: Navigating Legal and Regulatory Challenges Read More
Article | June 13, 2024 FDA Publishes Final Rule Related to the Regulation of Food Contact Notifications Read More
Article | June 12, 2024 Navigating HIPAA and State Privacy Laws for Drug and Device Manufacturers Read More